Blood Tests for Perimenopause
Why a normal FSH does NOT rule out perimenopause, the complete panel to discuss with your GP, and what conditions to exclude before attributing every symptom to hormones.
The Quick Answer
Perimenopause is the transition phase before menopause — the years when your ovarian function is declining but periods have not yet stopped for 12 consecutive months. It typically begins in the mid-40s (sometimes earlier) and lasts 4-10 years. It is fundamentally different from menopause in one key way: hormone levels are erratic, not consistently low. This is why a single blood test result is often misleading.
The most important fact about perimenopausal blood tests: a normal FSH does NOT exclude perimenopause. FSH can swing from 35 IU/L one month to 6 IU/L the next in the same woman. Australian menopause guidelines explicitly state that perimenopause is a clinical diagnosis — symptoms, cycle changes, and age are more reliable than any single hormone level.
What Happens in Perimenopause — and Why Blood Tests Behave Oddly
From birth, women have a fixed supply of eggs (follicles) in their ovaries. Each menstrual cycle, a cohort of follicles is recruited and one dominant follicle ovulates. As the ovarian reserve depletes through the 40s, the follicles become less responsive to FSH. The pituitary gland compensates by secreting more FSH — which is why FSH rises as perimenopause progresses.
But the process is not smooth. In early perimenopause, some cycles still ovulate normally (producing normal FSH and good oestradiol), while others do not (producing high FSH and low oestradiol). This is why FSH fluctuates so dramatically month-to-month. The graph of FSH over a year in perimenopause looks like a rollercoaster, not a gradual incline.
AMH (anti-Mullerian hormone) is the most clinically useful hormone test in perimenopause precisely because it does NOT fluctuate with the cycle — it reflects the total pool of small antral follicles, which declines steadily over years. A very low AMH for age indicates advanced ovarian ageing regardless of what FSH shows that particular day.
The Complete Perimenopause Blood Test Panel
Australian reference ranges from RCPA guidelines. Hormonal reference ranges are cycle-phase dependent and highly variable in perimenopause — always provide cycle day information to your lab.
FSH (follicle-stimulating hormone)
Key marker of menopausal transition — but highly variable. CRITICAL: FSH fluctuates wildly in perimenopause. One normal result does NOT rule it out. Always test on day 2-5 of the menstrual cycle for reproducibility. Repeat testing 4-6 weeks later if symptomatic but FSH is normal. Some women cycle between very high FSH (30+ IU/L) and normal within the same month.
Oestradiol (E2)
Reflects ovarian oestrogen output — erratic in perimenopause. Low or normal oestradiol with symptoms does not exclude perimenopause. Oestradiol can swing from very high (causing breast tenderness and heavy bleeding) to very low (causing hot flushes and insomnia) within the same cycle. A very high oestradiol with symptoms suggests the perimenopausal roller-coaster rather than true menopause.
AMH (anti-Mullerian hormone)
Most stable marker of remaining ovarian reserve and transition stage. Unlike FSH and oestradiol, AMH does not fluctuate with the cycle and can be tested on any day. Declines progressively as ovarian reserve diminishes. A very low AMH suggests advanced menopausal transition. Not routinely bulk-billed in Australia but available privately (approximately $60-90). Useful for women who want objective evidence of ovarian reserve.
LH (luteinising hormone)
Complement to FSH; confirms pituitary-ovarian axis status. LH surges trigger ovulation. In perimenopause, LH rises alongside FSH. Useful at baseline to confirm the pattern is consistent with ovarian failure rather than a pituitary problem. An FSH:LH ratio above 1 is typical of perimenopausal changes.
Progesterone (luteal phase)
Confirm whether ovulation is occurring. Test 7 days before expected period. Below 5-10 nmol/L suggests an anovulatory cycle — a hallmark of perimenopause. Consistently anovulatory cycles explain heavy irregular bleeding from oestrogen-dominant stimulation of the uterine lining. Useful if you want to understand your cycle pattern before discussing progesterone therapy.
TSH (thyroid stimulating hormone)
Exclude hypothyroidism — its symptoms are almost identical to perimenopause. This test must be done. Hypothyroidism causes fatigue, brain fog, weight gain, mood changes, irregular periods, and cold intolerance — all symptoms attributed to perimenopause. Thyroid disease incidence peaks in the 40s and 50s. Free T4 should be added if TSH is borderline. Treating underlying hypothyroidism alone can resolve most perimenopausal-appearing symptoms.
Free T4 and free T3
Active thyroid hormone levels — add if TSH is borderline. Add to TSH if TSH is borderline high (2.5-4.0 mU/L) with symptoms. Some women with TSH in the upper-normal range but low free T4 or T3 have subclinical hypothyroidism that responds to treatment. Also check thyroid antibodies (TPO and TgAb) if there is a family history of thyroid disease.
Ferritin and full blood count
Heavy perimenopausal periods commonly cause iron deficiency. Ferritin below 30 mcg/L indicates iron deficiency even with a normal haemoglobin — this is latent iron deficiency. Symptoms include fatigue, palpitations, poor concentration, restless legs, and hair loss, all of which mimic perimenopause. A full blood count (FBC) detects iron deficiency anaemia (low haemoglobin, low MCV). Both should be checked in any perimenopausal woman with heavy periods or significant fatigue.
Vitamin D (25-hydroxyvitamin D)
Deficiency causes fatigue, muscle aches, low mood — common in perimenopausal women. Vitamin D deficiency is very common in Australian women despite our climate — indoor work, sunscreen, and reduced outdoor time all contribute. Symptoms overlap with perimenopause. Declining oestrogen also accelerates bone loss, making vitamin D sufficiency critical for bone protection in the perimenopausal years.
Vitamin B12
Deficiency causes fatigue, brain fog, mood changes, tingling — all attributed to perimenopause. B12 deficiency is common in women over 40, especially those on metformin, long-term PPIs, or with dietary restrictions. Its symptoms (fatigue, brain fog, mood changes, poor memory, tingling) closely mimic perimenopause. Always check before attributing cognitive symptoms to hormonal change.
Fasting lipid panel
Cardiovascular risk rises as oestrogen declines in perimenopause. The perimenopausal transition is associated with a worsening lipid profile — LDL rises, HDL falls, and triglycerides increase as oestrogen levels decline. A baseline fasting lipid panel in the 40s provides a benchmark for monitoring cardiovascular risk through the transition.
HbA1c
Insulin resistance and diabetes risk increase during menopausal transition. Perimenopausal weight gain (particularly abdominal fat) and declining oestrogen worsen insulin sensitivity. Annual HbA1c monitoring from the late 40s is reasonable preventive medicine and can be done with the same blood draw as a lipid panel.
Common Perimenopausal Symptoms and Their Blood Test Correlates
Many perimenopausal symptoms are identical to other common conditions. Blood tests help identify which symptoms have a treatable non-hormonal cause and which are purely from the hormonal transition.
Irregular or heavy periods
The hallmark of perimenopause. Cycles become shorter, then longer, then unpredictable. Heavy bleeding from anovulatory (non-ovulating) cycles is very common. Check ferritin to rule out iron deficiency. If bleeding is very heavy or prolonged, a pelvic ultrasound to check endometrial thickness is warranted.
Hot flushes and night sweats
Vasomotor symptoms from falling oestrogen affecting hypothalamic temperature regulation. Not all women experience them. Fluctuating oestrogen (rising and falling) is more likely to cause hot flushes than steadily low oestrogen. They typically worsen as menopause approaches and resolve 1-5 years after the final period.
Sleep disruption
Both hot flushes and a direct effect of low progesterone on GABA receptors disrupt sleep. Poor sleep secondary to night sweats can be severe. Low ferritin also causes restless legs which disrupts sleep — check ferritin before attributing all sleep problems to hormones.
Brain fog and poor memory
Frequently reported and genuinely distressing. Caused by fluctuating oestrogen and sleep deprivation. However, low thyroid function, B12 deficiency, vitamin D deficiency, and iron deficiency can all cause identical cognitive symptoms. These four should always be excluded before concluding the brain fog is hormonal.
Mood changes, anxiety, or low mood
Oestrogen has significant effects on serotonin and dopamine pathways. Perimenopausal mood changes are real and physiological, not psychological weakness. Low progesterone in anovulatory cycles contributes. However, always check TSH and ferritin — hypothyroidism and iron deficiency are major contributors to low mood that are easily treated.
Very heavy bleeding with anaemia
A red flag requiring urgent assessment. Ferritin, FBC, and pelvic ultrasound are essential. Very heavy periods in perimenopause can cause significant iron deficiency anaemia. Other causes of heavy bleeding (fibroids, polyps, adenomyosis, endometrial hyperplasia) need to be excluded — not all heavy perimenopausal bleeding is purely hormonal.
Red Flags — When to Seek Urgent Help
These symptoms need same-day or urgent GP review — do not assume everything is perimenopause:
Very heavy bleeding soaking more than one pad per hour
Go to emergency or urgent care. This volume of blood loss can cause haemodynamic instability. Urgent FBC, ferritin, and coagulation tests are needed. IV iron or transfusion may be required. Not all heavy perimenopausal bleeding is benign — same-day assessment is appropriate.
Postmenopausal bleeding (12+ months since last period)
Any bleeding after 12 consecutive months of amenorrhoea must be investigated to exclude endometrial cancer. Pelvic ultrasound (endometrial thickness above 4 mm warrants biopsy) and GP or gynaecology review is urgent. This is NOT the same as late perimenopausal irregular bleeding.
Very low ferritin with symptoms of anaemia
Ferritin below 15 mcg/L with fatigue, palpitations, breathlessness, and pallor indicates iron deficiency anaemia from heavy periods. This needs treatment with oral or IV iron, and a plan to reduce the blood loss (hormonal or surgical). Do not wait for symptoms to worsen.
Periods stopping before age 40
Premature ovarian insufficiency (POI) affects 1% of women and is distinct from normal perimenopause. It requires specialist endocrinology assessment, chromosome testing, and early initiation of HRT to protect cardiovascular and bone health. Do not assume it is normal perimenopause if you are under 40.
Severe mood disturbance, suicidal ideation, or psychosis
Some women experience severe perimenopausal mood disturbance that goes beyond normal hormonal fluctuations. If mood changes are severe or there are thoughts of self-harm, seek same-day mental health review. This is not a normal part of perimenopause and is highly treatable with a combination of hormonal and psychiatric support.
New breast lump during perimenopause
Breast cancer incidence increases through the perimenopausal years. Any new breast lump, nipple discharge, skin dimpling, or nipple inversion warrants urgent GP assessment and mammogram regardless of age or HRT status. Do not attribute a new breast lump to hormonal changes without proper investigation.
The Perimenopause Diagnostic Pathway
Based on Australian Menopause Society and RANZCOG guidelines for perimenopausal assessment.
Initial comprehensive panel
FSH (day 2-5 of cycle), oestradiol, LH, TSH, free T4 (if TSH borderline), full blood count, ferritin, vitamin D, vitamin B12, fasting lipid panel, HbA1c. This single panel excludes the major masqueraders (thyroid disease, iron deficiency, B12 deficiency, vitamin D deficiency) and establishes hormonal baseline.
If FSH is normal but symptoms persist: repeat
Repeat FSH on day 2-5 of the next cycle, 4-6 weeks later. A single normal FSH does NOT exclude perimenopause. Also add AMH if not yet tested — AMH is cycle-independent and gives a stable picture of ovarian reserve regardless of cycle day.
Progesterone if cycle timing is uncertain
Luteal-phase progesterone (day 18-23, or 7 days before expected period) confirms whether ovulation is occurring. Below 10 nmol/L in the mid-luteal phase suggests anovulation — a key perimenopausal feature. Useful if you are experiencing irregular cycles and want to understand the pattern.
Pelvic ultrasound for heavy bleeding
If periods are very heavy or prolonged, a transvaginal ultrasound measures endometrial thickness and excludes fibroids, polyps, and adenomyosis. All these conditions worsen in perimenopause and require specific management beyond hormone therapy. This is a GP or gynaecologist referral, not a blood test, but it completes the assessment.
DEXA bone density scan if early or symptomatic
Consider a DEXA scan if perimenopause starts before 45 (early menopause), if you have risk factors for osteoporosis (low body weight, smoking, steroid use, family history, previous fracture), or if bone pain is a symptom. Declining oestrogen accelerates bone loss from the perimenopausal years onwards.
Annual reviews once in the transition
Annual bloods: TSH, ferritin, FBC, vitamin D, vitamin B12, fasting lipid panel, HbA1c. These track the metabolic and nutritional changes of the transition. FSH and oestradiol are only useful to repeat if you are considering or reviewing hormone therapy. AMH need only be tested once.
Reassess if starting HRT
If you start hormone therapy, an oestradiol level 3 months after starting confirms absorption and guides dose adjustment. Restart the cardiovascular monitoring cycle (lipids, blood pressure, liver enzymes for oral preparations) as described in the HRT monitoring guide.
Lifestyle Strategies for the Perimenopausal Transition
Resistance training for bone and muscle
ExerciseBone loss accelerates in perimenopause as oestrogen declines. Weight-bearing and resistance exercise (weights, resistance bands, Pilates, yoga with loading) is the most effective non-hormonal intervention for bone density. Aim for 2-3 sessions per week. Muscle mass also declines from the mid-40s — strength training preserves it.
Sleep hygiene and temperature regulation
SleepA cool bedroom (18-20 degrees Celsius), moisture-wicking bedding, and avoiding alcohol and spicy food before bed reduces night sweat severity. Cognitive behavioural therapy for insomnia (CBTi) is evidence-based for perimenopausal sleep disruption. Melatonin can help with sleep onset if wakefulness is the main issue.
Mediterranean or whole-food diet
Metabolic healthReduces cardiovascular risk, supports gut microbiome health, and helps stabilise mood and energy through the transition. Reducing refined carbohydrates and added sugar helps counter the insulin resistance that develops as oestrogen declines. Prioritise omega-3 fats (oily fish, walnuts, flaxseed), legumes, and colourful vegetables.
Calcium and vitamin D for bone protection
Bone healthAim for 1000-1300 mg of calcium from food daily (dairy, fortified milks, canned sardines, almonds). If dietary calcium is adequate, supplementation adds little benefit and may carry cardiovascular concerns. Vitamin D supplementation to achieve above 75 nmol/L is almost always warranted in perimenopausal Australian women.
Alcohol reduction
Hormone balanceAlcohol disrupts sleep (reducing deep sleep and increasing night sweats), raises oestradiol levels, and increases breast cancer risk. Even modest alcohol intake (4-7 drinks per week) measurably worsens hot flushes and sleep quality in perimenopausal women. Reducing to under 4 drinks per week often produces noticeable improvement in symptoms.
Discuss HRT with an informed GP
TreatmentModern body-identical transdermal HRT is highly effective for perimenopausal symptoms and has a favourable safety profile for most women. Australian prescriptions have risen significantly as the evidence has been re-evaluated. If your GP is not comfortable prescribing or discussing HRT, ask for a referral to the Australian Menopause Society practitioner directory at menopause.org.au.
Track your cycle with an app
MonitoringApps like Clue, Natural Cycles, or even a simple paper diary help you identify cycle shortening or lengthening, the frequency of missed periods, and symptom patterns. This information is invaluable when discussing perimenopause with your GP and helps identify the optimal cycle-day timing for blood tests.
Related Reading
Got Your Perimenopause Blood Results?
Upload your blood test PDF and SmarterBlood's AI will explain every marker in plain English — FSH, oestradiol, AMH, TSH, ferritin — with Australian reference ranges and what each result means for your hormonal health.
This page provides general educational information about blood tests in perimenopause. Perimenopause is a clinical diagnosis and no blood test alone confirms or excludes it. Always discuss your results and symptoms with your GP or a menopause-trained practitioner. SmarterBlood does not provide medical care.